Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07574645 · ClinicalTrials.gov registry record
Spinal Dural Arteriovenous Fistula International Data and Outcomes Registry
A clinical trial, sponsored by Thomas Jefferson University.
- Recruiting
- Registry status
- 1,000
- Enrollment target
NCT07574645 is a clinical trial that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 1,000 participants.
The verdict
NCT07574645 is actively recruiting participants, sponsored by Thomas Jefferson University.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
Given the lack of large multicenter datasets in the context of Spinal arteriovenous fistula, the strength of the evidence surrounding this rare disease is limited. SPIDER hence aims to address that by compiling patient-level data from centers all around the world.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2026-01-05 |
| Est. Completion | 2026-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07574645
The ClinicalTrials.gov registry entry for NCT07574645 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07574645 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07574645 about?
NCT07574645 is a clinical study titled "Spinal Dural Arteriovenous Fistula International Data and Outcomes Registry". Given the lack of large multicenter datasets in the context of Spinal arteriovenous fistula, the strength of the evidence surrounding this rare disease is limited. SPIDER hence aims to address that by compiling patient-level data from centers all around the world.
What is the current status of trial NCT07574645?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2026-01-05. Estimated completion is 2026-05.
Who is sponsoring clinical trial NCT07574645?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.